Hims & Hers Health, Inc. (NYSE:HIMS) COO Sells $2,653,246.61 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird sold 85,561 shares of the stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $31.01, for a total transaction of $2,653,246.61. Following the completion of the transaction, the chief operating officer now owns 630,986 shares in the company, valued at $19,566,875.86. This trade represents a 11.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Melissa Baird also recently made the following trade(s):

• On Monday, November 18th, Melissa Baird sold 58,750 shares of Hims & Hers Health stock. The shares were sold at an average price of $21.04, for a total transaction of $1,236,100.00.
• On Monday, October 7th, Melissa Baird sold 58,750 shares of Hims & Hers Health stock. The stock was sold at an average price of $19.57, for a total transaction of $1,149,737.50.

Hims & Hers Health Price Performance

NYSE HIMS opened at $30.02 on Friday. The stock has a market capitalization of $6.56 billion, a PE ratio of 68.23 and a beta of 1.25. Hims & Hers Health, Inc. has a 1-year low of $8.09 and a 1-year high of $35.02. The business has a 50 day simple moving average of $24.78 and a two-hundred day simple moving average of $20.97.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, November 4th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.26. The firm had revenue of $401.56 million during the quarter, compared to analyst estimates of $382.20 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. Hims & Hers Health’s revenue for the quarter was up 77.1% compared to the same quarter last year. During the same period last year, the firm posted ($0.04) earnings per share. On average, analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Piper Sandler reiterated a “neutral” rating and set a $21.00 target price (up from $18.00) on shares of Hims & Hers Health in a research report on Tuesday, November 5th. Bank of America cut Hims & Hers Health from a “buy” rating to an “underperform” rating and lowered their price objective for the company from $32.00 to $18.00 in a research report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a research note on Wednesday, November 6th. Canaccord Genuity Group lifted their price target on shares of Hims & Hers Health from $28.00 to $38.00 and gave the company a “buy” rating in a report on Monday, December 2nd. Finally, TD Cowen reissued a “buy” rating and issued a $28.00 price objective on shares of Hims & Hers Health in a research note on Wednesday, November 20th. One analyst has rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $21.43.

Institutional Trading of Hims & Hers Health

A number of large investors have recently made changes to their positions in HIMS. Nisa Investment Advisors LLC grew its position in Hims & Hers Health by 679.2% in the second quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock worth $37,000 after acquiring an additional 1,603 shares in the last quarter. Quest Partners LLC boosted its holdings in shares of Hims & Hers Health by 5,944.1% in the 2nd quarter. Quest Partners LLC now owns 3,566 shares of the company’s stock worth $72,000 after purchasing an additional 3,507 shares during the period. CWM LLC increased its position in shares of Hims & Hers Health by 21.4% during the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after purchasing an additional 1,054 shares during the last quarter. Van ECK Associates Corp purchased a new stake in Hims & Hers Health during the 2nd quarter valued at $111,000. Finally, Quarry LP lifted its position in Hims & Hers Health by 91.0% in the third quarter. Quarry LP now owns 6,113 shares of the company’s stock worth $113,000 after buying an additional 2,913 shares during the last quarter. 63.52% of the stock is currently owned by institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.